A patient with severe postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS) received immunotherapy with low-dose naltrexone (LDN) and intravenous immunoglobulin ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

Jankistomig is designed as a dual-pathway, single agent, IgG therapy targeting immune checkpoint inhibition and angiogenesis in the treatment of cancer. The company added Roger Dansey to its board of ...

We award CSL a narrow moat rating based on the cost advantage afforded by its large-scale plasma collection and fractionation, and intangible assets based on the intellectual capital in its existing ...

At Marshfield Children’s Hospital, Dr. Dolly Paw-ton, the facility dog, is helping make them happen. One Wausau family sees ...

Monoclonal antibodies (mAb) are a major focus of the pharmaceutical industry, and polyclonal immunoglobulin G (IgG) therapy is used to treat a wide variety of health conditions. As some individuals ...

Suggested thresholds for administering immunoglobulin replacement therapy are generally an immunoglobulin G level of less than 400–500 g/dL or the presence of serious or recurrent infection. 70,98 ...